Published: 2017-01-02

HS-C reactive protein and red blood cell distribution width as effective markers for hypertension

G. Pavan Kumar Reddy, Kande V. Mallikarjuna Rao


Background: Hypertension or elevated blood pressure is one of the leading causes of morbidity and mortality. Hs-CRP, which is a known marker for CVD, is also one of the predictive markers of inflammation processes which result in hypertension. Increased RDW is also believed to be associated with CVD morbidity and mortality in patients with previous myocardial infarction, brain vascular disease, strokes, septicemia, chronic obstructive pulmonary disease and hepatitis B.

Methods: 200 patients 100 male and 100 females and 50 each of controls were selected for the study. Complete demographic details were collected from all the patients including the age, sex, height, weight, BMI, smoking/non-smoking status, alcoholism etc. After a thorough clinical examination, venous blood was collected from all the patients after an overnight fast for lipid profile, hs-CRP and complete blood count.

Results: The patients in both males and females had a higher BMI than that of the controls. Hs-CRP levels in males was 1.64 mg/L and in females it was 1.47 mg/L. Significant difference was seen in the RDW values also in the patients.

Conclusions: Hs-CRP levels and RDW levels are both equally effective as a predictive marker for hypertension.


Hs-CRP, Red blood cell distribution width, Hypertension

Full Text:



Kulkarni AT. Hypertension- a silent killer. Indian Medical Gazette.1998;32(3):73-7.

Park K. Text Book of P.S.M. 20th edn. M/s Banarsidas Bhanot Publishers. 2009;323-7.

Whitworth JA. World Health Organization, International society of hypertension writing group. World Health Organization (WHO)/international society of hypertension (ISH) statement on management of hypertension. J Hypertens. 21(11):1983-92.

Gupta R. Trends in hypertension epidemiology in India. J Human Hypertens. 2004;18:73-8.

Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, Izzo JL Jr. Seventh report of the Joint National Committee on prevention, detection, evaluation and treatment of high blood pressure 2003;42(6):1206-52.

Bots M, Nikitin Y, Salonen J, Elwood P, Malyutina S, Freire D. Left ventricular hypertrophy and risk of fatal and non-fatal stroke. J Epidemion Comm Health. 2002;56:8-13.

Pearson TA, Mensah GA, Alexander RW, Anderson JL, Cannon RO, Criqui M. Markers of inflammation and cardiovascular disease: application to clinical and public health practice: a statement for healthcare professionals from the centres for disease control and prevention and the American Heart Association. Circulation. 2003;107:499-511.

Wilson AM1, Ryan MC, Boyle AJ. The novel role of C-reactive protein in cardiovascular disease: Risk marker or pathogen. Int J Cardiol. 2006;106:291-7.

Vigushin DM, Pepys MB, Hawkins PN. Metabolic and scintigraphic studies of radioiodinated human C-reactive protein in health and disease. J Clin Invest. 1993;91(4):1351-7.

Demir A, Yarali N, Fisgin T, Duru F, Kara A. Most reliable indices in differentiation between thalassemia trait and iron deficiency anaemia. Pediatrics Intern. 2002;44(6):612-6.

Perlstein TS, Weuve J, Pfeffer MA, Beckman JA. Red blood cell distribution width and mortality risk in a community-based prospective cohort. Arch Intern Med. 2009;169(6):588-94.

Patel KV, Ferrucci L, Ershler WB, Newman AB, Fried LP, Wallace RB, Bandinell S. Red blood cell distribution width and the risk of death in middle-aged and older adults. Arch Intern Med. 2009;169:515-23.

Tonelli M, Sacks F, Arnold M, Moye L, Davis B, Pfeffer M. Relation between red blood cell distribution width and cardiovascular event rate in people with coronary disease. Circulation. 2008;117(2):163-8.

Förhécz Z, Gombos T, Borgulya G, Pozsonyi Z, Prohászka Z, Jánoskuti L. Red cell distribution width in heart failure: prediction of clinical events and relationship with markers of ineffective erythropoiesis, inflammation, renal function, and nutritional state. American Heart J. 2009;158(4)659-66.

Kim J, Kim YD, Song T-J, Park JH, Lee HS, Nam CM. Red blood cell distribution width is associated with poor clinical outcome in acute cerebral infarction. Thrombosis and Haemostasis. 2012;108(2)349-56.

Lou Y, Wang M, Mao W. Clinical usefulness of measuring red blood cell distribution width in patients with hepatitis B. PLoS One. 2012;7(5):e37644.

Macdougall IC, Cooper A. The inflammatory response and erythropoiesis sensitivity. Nephrol Dial Transplant. 2002;17(1):48-52.

Jithesh TK, Mathew R, Jayapal V, Vijayakumar T. Red cell distribution width and high sensitivity C-reactive protein as risk markers in hypertension. Int J Med Sci Pub Health. 2012;1:138-42.

Perkins SL. Examination of blood and bone marrow. In: Greer JP, Foerster J, Lukens JN, Rodgers GM, Paraksevas F, Glader BE, eds. Wintrobe’s clinical hematology. 11th ed. Salt Lake City: Lippincott Wilkins & Williams; 2003:5-25.

Evans TC, Jehle D. The red blood cell distribution width. J Emerg Med. 1991;9(1):71-4.

Arhan M, Önal IK, Adnan TAŞ, Kurt M, Kalkan IH, Özin Y. The role of red cell distribution width as a marker in inflammatory bowel disease. Turk J Med Sci. 2011;41(2):227-34.

Wen Y. High red blood cell distribution width is closely associated with risk of carotid artery atherosclerosis in patients with hypertension. Exp Clin Cardiol. 2010;15(3):37-40.